Pilot trial evaluates safety and efficacy of high-dose rTMS to reduce apathy in adults with chronic stroke, indicating promising outcomes.
To evaluate the safety, feasibility, tolerability, and preliminary efficacy of accelerated high-dose repetitive transcranial magnetic stimulation (rTMS) targeting the dorsomedial prefrontal cortex (dmPFC) to reduce apathy in adults with chronic stroke.
No takes yet. Share an insight, caveat, or question.
Grewal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: